NCT05579444 2023-12-15Systems Biology of Gastrointestinal and Related DiseasesViomeTerminated17 enrolled
NCT02574637 2021-05-26Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's DiseaseAstraZenecaPhase 2 Terminated29 enrolled 25 charts
NCT00584740 2015-03-31Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's DiseaseNovartisPhase 2 Terminated59 enrolled 13 charts